Chemomab Therapeutics earnings were -$14.4M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest CMMB earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$3.5M, down 4.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CMMB reported annual earnings of -$24.2M, with -12.4% growth. The next CMMB earnings date is Mar 5, 2025.
Chemomab Therapeutics Earnings Reports & History FAQ
What were Chemomab Therapeutics's earnings last quarter?
On CMMB's earnings call on Invalid Date, Chemomab Therapeutics (NASDAQ: CMMB) reported Q3 2024 earnings per share (EPS) of -$0.20, up 41.18% year over year. Total CMMB earnings for the quarter were -$3.48 million. In the same quarter last year, Chemomab Therapeutics's earnings per share (EPS) was -$0.34.
The next CMMB earnings date is Invalid Date. Add CMMB to your watchlist to be reminded of Chemomab Therapeutics's next earnings date.
What was CMMB's earnings growth in the past year?
As of Chemomab Therapeutics's earnings date in Invalid Date, Chemomab Therapeutics's earnings has grown year over year. CMMB earnings in the past year totalled -$14.40 million.
Is Chemomab Therapeutics profitable or losing money?
As of the last Chemomab Therapeutics earnings report, Chemomab Therapeutics is currently losing money. Chemomab Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$14.40 million, a 50.48% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.